Sign in

Vitamin D significantly reduces Covid mortality: PGIMER study

The use of Vitamin D in high doses, especially injectable preparations, should be strongly discouraged, the doctors say

Published on: Jul 7, 2021, 01:48:16 IST
By , Chandigarh
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

An analysis by the doctors at Post Graduate Institute of Medical Education and Research (PGIMER) shows that the use of Vitamin D in Covid-19 significantly leads to improved clinical outcomes—reduction in mortality and intensive care unit admission.

Pooled data from 13 studies with 2,933 Covid-19 patients showed that Vitamin D supplemented after the diagnosis of Covid-19 leads to improved clinical outcomes in terms of reduced mortality and/or intensive care unit admission. (AP)
Pooled data from 13 studies with 2,933 Covid-19 patients showed that Vitamin D supplemented after the diagnosis of Covid-19 leads to improved clinical outcomes in terms of reduced mortality and/or intensive care unit admission. (AP)

The doctors, however, warn against irrational use of Vitamin D, as it can be toxic.

The study, ‘Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis’, recently published in the Journal of Endocrinological Investigation, was conducted by Dr Rimesh Pal, Dr Mainak Banerjee, professor Sanjay K Bhadada, Dr Anirudh J Shetty of the endocrinology department of PGIMER; Dr Birgurman Singh of Government Medical College, Patiala; and Dr Abhinav Vyas of Rabindranath Tagore Medical College, Udaipur.

“As Covid-19 continues to rampage, the search for an effective therapy still remains elusive. Accordingly, multiple existing drugs have been repurposed for Covid management. In this context, Vitamin D, a fat-soluble vitamin, which is primarily related to bone and mineral metabolism, has shown some promising results,” said Dr Sanjay K Bhadada, head of the endocrinology department, PGIMER.

“Pooled data from 13 studies with 2,933 Covid-19 patients showed that Vitamin D supplemented after the diagnosis of Covid-19 leads to improved clinical outcomes in terms of reduced mortality and/or intensive care unit admission,” said Dr Bhadada.

The study lends ample support to the fact that Vitamin D can be used as an effective adjuvant treatment in patients hospitalised with Covid-19.

He said that the anti-viral and the immune modulatory role of Vitamin D were perhaps helpful in this regard. Nevertheless, the irrational and rampant use of Vitamin D to prevent Covid-19 should not be a norm: “The use of Vitamin D in high doses, especially injectable preparations, to treat Covid-19 should be strongly discouraged. Vitamin D, supplemented prior to the diagnosis of Covid-19, was not found to improve clinical outcomes in our meta-analysis. And overuse can lead to Vitamin D toxicity,” explained the doctor.

  • Tanbir Dhaliwal
    ABOUT THE AUTHOR
    Tanbir Dhaliwal

    Tanbir Dhaliwal is a correspondent at Chandigarh. She covers health and business.